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Abstract
Background: High-risk patients in the pediatric intensive care unit (PICU) contribute substantially to PICU-mortality.
Complex chronic conditions (CCCs) are associated with death. However, it is unknown whether CCCs also increase
mortality in the high-risk PICU-patient. The objective of this study is to determine if CCCs or other factors are
associated with mortality in this group.
Methods: Retrospective cohort study from a national PICU-database (2006–2012, n = 30,778). High-risk PICU-
patients, defined as patients < 18 years with a predicted mortality risk > 30% according to either the recalibrated
Pediatric Risk of Mortality-II (PRISM) or the Paediatric Index of Mortality 2 (PIM2), were included. Patients with a
cardiac arrest before PICU-admission were excluded.
Results: In total, 492 high-risk PICU patients with mean predicted risk of 24.8% (SD 22.8%) according to recalibrated
PIM2 and 40.0% (SD 23.8%) according to recalibrated PRISM were included of which 39.6% died. No association was
found between CCCs and non-survival (odds ratio 0.99; 95% CI 0.62–1.59). Higher Glasgow coma scale at PICU
admission was associated with lower mortality (odds ratio 0.91; 95% CI 0.87–0.96).
Conclusions: Complex chronic conditions are not associated with mortality in high-risk PICU patients.
Keywords: Child, Critical care, Mortality, Outcome assessment (healthcare)
Background
Patients with a high predicted mortality risk in the
pediatric intensive care unit (PICU) are a challenge to
the clinical team. The relatively small subset of these
patients contributes substantially to the number of non-
survivors and to PICU-resources. Around 1% of the
PICU-admissions in the Australian and New Zealand
Paediatric Intensive Care Registries (ANZPIC) has a
predicted mortality risk between 30 and 100%, but this
small cohort contributes to one third of all deaths [1–3].
Complex chronic conditions (CCCs) are associated
with prolonged length of stay in PICU patients, un-
planned readmissions and death [4, 5]. A CCC is defined
as ‘any medical condition that can be reasonably
expected to last at least 12 months (unless death
intervenes) and to involve either several different organ
systems or 1 organ system severely enough to require
specialty pediatric care and probably some period of
hospitalization in a tertiary care center’ [6]. There are
many CCCs in several organ systems. Examples are
spinal cord malformations, cystic fibrosis, hypoplastic
left heart syndrome, extreme immaturity, metabolic
disorders, etc. [7] Besides CCCs there are so called ‘non-
complex chronic conditions’ (NCCCs), diagnoses that
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could be expected to last > 12months but not meeting
the additional CCC criteria. Examples of NCCCs are
asthma, atrial septal defect, obesity, etc. [4]. The preva-
lence of CCCs among hospitalized patients and among
PICU patients is increasing [4]. Only few CCCs are in-
corporated in severity-of illness models like Paediatric
Index of Mortality (PIM (2,3)) and Pediatric Risk of
Mortality (PRISM (II, III, IV) [4, 8–12]. In low-risk
PICU-patients (patients with predicted mortality risk
< 1%) CCCs and unplanned admissions are associated
with death (OR 3.29, 95% CI 1.97–5.50) [13, 14]. It is
unknown whether CCCs increase mortality in the high-
risk PICU patient as well.
Therefore, the aim of the present study is to determine
if CCCs or other identifiable factors are associated with
death in high-risk PICU-patients.
Methods
Study population
Patients were derived from a national PICU database
containing data from all pediatric intensive care depart-
ments in the Netherlands (2006–2012, n = 30,778); the
‘PICE-registry’ [13, 15]. The same cohort was used in a
previous study on low-risk PICU-patients [13]. Patients
< 18 years old with a high predicted mortality risk were
included in the study. High-risk was defined as a pre-
dicted mortality risk > 30% according to either the
PRISM II (referred to as PRISM) or the PIM2 risk score
[9, 10]. In this study, as described before, both models
were recalibrated to predict the overall mortality in the
total population in this particular 6-year period without
altering the relative weights of risk factors in the models
and thus retaining the discriminative power of the
original models [13, 15].
Patients who were already dead before PICU admis-
sion (e.g., patients admitted for organ transplantation
already being brain-dead) or patients admitted for pallia-
tive care, patients dying within 2 h of PICU admission,
and patients transferred to another ICU during their
PICU treatment were excluded from the study. Data of
patients that did not pass quality control during local
site audit visits and were excluded from the annual re-
ports were also excluded from the study [13]. Patients
with a cardiac arrest prior to PICU admission were
excluded due to possible bias of the results [16, 17].
Design
Retrospective cohort study based on data prospectively
collected in a national registry.
Risk variables and data-handling
Variables that were analysed represented many aspects of
the PICU stay, including admission characteristics, physio-
logical state, diagnoses and outcome. Non-survivors were
defined as patients who died in the PICU. The ANZPIC
diagnostic code list was used in the PICE-registry [18]. Pa-
tients were classified as patients with a CCC if either the
primary diagnosis, underlying diagnosis or first additional
diagnosis was a CCC [6, 7]. Patients were classified as hav-
ing a NCCC if the primary diagnosis, underlying diagnosis
or first additional diagnosis was a diagnosis defined as a
NCCC. A modified Feudtner’s list was used to classify
diagnoses into CCC or NCCC [4, 6, 7, 18]. ANZPIC
diagnoses not appearing on these lists were classified
according to expert opinion (C.V. and J.L.). The list of
CCC-diagnoses was recently published [13]. Definitions of
‘Admission outside office hours’, ‘readmission’ and ‘special-
ized transport’ were published previously [13]. The data
were checked for non-valid data. Illogical and impossible
values that surpassed physiologic threshold values were
excluded if the value likely resulted from a typo or meas-
urement error, as described before. (Examples of typo/
measurement errors: diastolic blood pressure > 400
mmHg, low paO2 in combination with cyanotic congeni-
tal heart disease which by definition should be excluded
from PRISM score.) [13].
Statistical analysis
Depending on distribution, continuous variables were
tested using an independent T test or Mann-Whitney U
test. For dichotomous variables, chi-square test or, in
case of small expected frequencies, Fisher’s exact test
was used. To adjust for multiple testing, Bonferroni
correction was performed and differences were consid-
ered statistically significant if p-value was < 0.001.
For the multivariable logistic regression analysis, only
risk factors that were present at the time of admission
were included in the regression analysis. Because the
selection of the study population was based on PIM2
and PRISM scores, predictors from these scores were
not included in the multivariable logistic regression
analysis, except for the Glasgow Coma Scale (GCS) at
admission.
Statistical analyses were carried out using IBM SPSS
Statistics Version 22.1.
Results
Population characteristics
In total, there were 30,778 admissions of which 738 pa-
tients were high-risk patients (Fig. 1, Additional file 1:
Table S3). After excluding patients with cardiac arrest
before PICU admission, a total of 492 high-risk patients
was included with a mortality rate of 39.6%. The mean
predicted mortality risk of these 492 patients was 24.8%
(SD: 22.8%) according to the recalibrated PIM2 and
40.0% (SD: 23.8%) according to the recalibrated PRISM.
The majority of the high-risk patients had an unplanned
admission for medical reasons.
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Analysis of differences
Baseline characteristics are shown in Table 1. The
median GCS at time of admission was significantly
higher in survivors compared to non-survivors (me-
dian 15 vs. median 12, respectively; p < 0.001). Both
PRISM and PIM2 mortality risks were significantly
lower in survivors compared to non-survivors. Venti-
lator-days and length of stay were longer in survivors
compared to non-survivors. No other significant dif-
ferences were found.
Factors associated with survival
Higher GCS at admission was associated with lower
mortality (OR 0.91; 95% CI 0.87–0.96) (Table 2). No as-
sociation was found between CCCs and non-survival
(OR 0.99; 95% CI 0.62–1.59). No other factors were as-
sociated with mortality. Results from the unadjusted
ORs are shown in (Additional file 1: Table S3).
Discussion
In this large retrospective cohort study in high-risk
PICU patients, complex chronic conditions were not
associated with mortality.
This is different compared to our previous study
looking into low-risk admissions, where CCCs were
associated with increased mortality [13]. In a general
PICU-population, without risk stratification, a similar
association was found [4]. Although some CCCs (for
example: leukemia, hypoplastic left heart syndrome) are
incorporated in the PIM2, the majority of CCCs is not
part of the risk models. Having a chronic disease is often
not reflected in physiological values and therefore not
shown as a higher mortality risk. CCCs can be very het-
erogeneous. Some CCCs might be associated with death
in the PICU (e.g. a patient with a complex heart
disorder) while other CCCs are not lethal but may have
impact on other outcome parameters like functional out-
come. Furthermore, it’s possible that some patients with
Fig. 1 Flowchart of the population
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Table 1 Population characteristics and differences between high-risk survivors and non-survivors
Characteristic Survivors n = 297 Non-survivors n = 195 p value
Male 179 (60.3) 105 (53.8) 0.16
Age < 12months 161 (54.2) 90 (46.2) 0.08
Unplanned admission 275 (92.6) 182 (93.3) 0.76
Medical admission 227 (76.4) 146 (74.9) 0.69
Readmission < 48 h 4 (1.3) 3 (1.5) 0.86
Admission outside office hours 151 (50.8) 96 (49.2) 0.73
Mode of transport upon admission
None 159 (53.5) 104 (53.3) 0.97
Non-specialized transport 52 (17.5) 20 (10.3) 0.03
Specialized transport 107 (36.0) 84 (43.1) 0.12
Season of admission
Winter 74 (24.9) 46 (23.6) 0.74
Spring 64 (21.5) 51 (26.1) 0.24
Summer 59 (19.8) 50 (25.6) 0.13
Autumn 100 (33.7) 48 (24.6) 0.03
Recovery as reason for PICU admission 22 (7.4) 15 (7.7) 0.91
PRISM recalibrated mortality risk, median [IQR] 0.36 [0.15–0.48] 0.44 [0.31–0.66] < 0.001
PIM2 recalibrated mortality risk, median [IQR] 0.14 [0.05–0.34] 0.21 [0.09–0.46] < 0.001
Patients with
PRISM > 30% (and PIM < 30%) 190 (64.0) 115 (59.0) 0.26
PIM2 > 30% (and PRISM < 30%) 89 (30.0) 43 (22.1) 0.05
PRISM and PIM2 > 30% 18 (6.1) 37 (19.1) < 0.001
Chronic conditions
No chronic condition 82 (27.6) 68 (34.9) 0.09
NCCC 19 (6.4) 7 (3.6) 0.17
CCC 196 (66.0) 120 (61.5) 0.31
Diagnose groups
Trauma 9 (3.0) 16 (8.2) 0.01
Cardiovascular 30 (10.1) 22 (11.3) 0.68
Neurological 30 (10.1) 31 (15.9) 0.06
Respiratory 79 (26.6) 29 (14.9) 0.002
Renal 2 (0.7) 1 (0.5) 0.82
Gastrointestinal 14 (4.7) 12 (6.2) 0.49
Post procedure diagnosis 45 (15.2) 32 (16.4) 0.71
Miscellaneous 88 (29.6) 52 (26.7) 0.48
Glasgow Coma Scale at admission 15 [9–15] 12 [3–15] < 0.001
Mechanically ventilated (n = 660) 260 (91.5) 178 (97.8) 0.01
Outcome
Number of days mechanically ventilated, median [IQR] 7 [4–13] 3 [2–7] < 0.001
Length of stay PICU, median [IQR] 12 [7–21] 3 [2–7] < 0.001
Data are presented as n (%), unless mentioned otherwise
[IQR] is defined as interquartile range: [25th percentile – 75th percentile]
NCCC non-complex chronic condition, CCC complex chronic condition
The physiological parameters are the most abnormal values collected in the first 24 h after admission
Verlaat et al. BMC Pediatrics          (2019) 19:274 Page 4 of 6
CCCs may be refused PICU admission and thus not
contribute to the overall PICU mortality. We did not in-
vestigate this and therefore this statement is conjecture.
In true high-risk patients other factors like the GCS have
a clearer influence on mortality for patients with CCCs.
Our study has several limitations. First, an arbitrary
choice was made for the definition of high-risk patients,
using a combination of PIM2 and PRISM scores with a
certain cut-off point. Both models use different predic-
tors and different time windows to calculate their scores
and do not give the same result. Because in the Dutch
PICE registry both models are used and no model is su-
perior to another, we used a combination of both
models. Using only one model instead of a combination
might underestimate a cohort of high-risk patients. Only
a minority had a mortality risk of > 30% in both models.
Mean predicted mortality was higher according to
PRISM compared to PIM2. However, if only PRISM
model had been used to detect high-risk patients,
roughly a third of the high-risk cohort would not have
been detected.
Third, an older version of the PRISM was used, dating
from 1988 [10]. If the original PRISM model would have
been used without recalibration, the predicted mortality
would have been overestimated. However, because the
PRISM was recalibrated to fit, it is a good predictor of
mortality [15].
Fourth, no factors which are part of the PIM2/PRISM
models were used for the multivariable logistic regres-
sion analysis, with the exception of the GCS at admis-
sion. The GCS at admission is not incorporated in the
PIM2 model but is indirectly part of the PRISM score as
a dichotomous variable. If the GCS within the first 24 h
is less than 8, the PRISM score increases. However, a
mild decrease in GCS such as GCS between 8 and 10
does not increase PRISM score, although there might be
a serious neurological condition. We found a significant
and clinically important lower GCS in non-survivors.
This difference could not be explained by cardiac arrest
patients. Therefore we decided to add the GCS as a
continuous variable in the analysis.
Conclusions
Complex chronic conditions are not associated with
mortality in PICU patients with a high predicted mortal-
ity-risk, in contrast to low-risk PICU patients. We rec-
ommend to explore the role of CCCs in (PICU) patients
with different risk profiles further. Higher Glasgow coma
scale at PICU admission was associated with lower
mortality.
Additional file
Additional file 1: Table S3. Variables associated with mortality survival
in the high-risk group. (DOCX 12 kb)
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